News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
ICR family charity partner celebrated in King’s Birthday Honours List

18/06/24

The Institute of Cancer Research, London, congratulates the founders of the Chris Lucas Trust, our family charity partner, who are among those recognised in The King’s Birthday Honours List.
ICR Logo
Seed financing announcement for new ICR and Oxford spinout company Kodiform Therapeutics

11/06/24

Kodiform Therapeutics, a new joint spin-out company from The Institute of Cancer Research, London, and the University of Oxford, has received a major seed funding investment from venture creation firm Oxford Science Enterprises.
ICR Logo
Thousands take part in Dave Day tribute to Hairy Biker Dave Myers in support of The Institute of Cancer Research

10/06/24

Hundreds of thousands of people from across the country came together on Saturday to celebrate the life of the late Hairy Bakers TV star Dave Myers and raise thousands for our vital research.
ICR Logo
ASCO 2024: New ultra-sensitive blood test predicts recurrence of breast cancer, months or even years before relapse

01/06/24

A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, London, has shown.
ICR Logo
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test

31/05/24

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one group of men than the current standard blood test, a new study reports.
ICR Logo
Scientists uncover new treatment pathway for rare ‘spider web’ childhood brain tumours

24/05/24

ICR researchers have identified the unique features of an exceptionally rare set of childhood brain tumours – a discovery that could pave the way for more effective treatments.
ICR Logo
New way to kill cancer cells could lead to longer lasting protection for people with breast cancer

23/05/24

Killing breast cancer cells in a way that trains the immune system to recognise and destroy residual cancer cells could offer longer lasting protection to people with the disease.
axel behrens 547x410
Professor Axel Behrens elected as Fellow of the Academy of Medical Sciences

21/05/24

Professor Axel Behrens, Scientific Director of the Cancer Research UK Convergence Science Centre and leader of the Cancer Stem Cell Group at The Institute of Cancer Research, London, has been awarded a prestigious Fellowship by the Academy of Medical Sciences.
Proliferating cells in a tumour organoid of triple-negative breast cancer. Image credit: Dr Rebecca Marlow / ICR
Researchers identify what drives PARP inhibitor resistance in advanced breast cancer

08/05/24

Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease.
ICR Logo
New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy

08/05/24

Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
ICR Logo
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer

02/05/24

Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body.
Professor Ros Eeles
New screening trial to save thousands of men’s lives from prostate cancer

30/04/24

Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate cancer and double the number of lives saved.


Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.